ConductScience.org, home

Paper · 41567673

Relationship between different blood routine parameters and different types of sudden deafness and prognosis.

Zhang Q and 3 others. Front Med (Lausanne), 2025. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Relationship between different blood routine parameters and different types of sudden deafness and prognosis. Papers, record 41567673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41567673

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relationship between different blood routine parameters and different types of sudden deafness and prognosis.
PubMed
Journal
Front Med (Lausanne)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-01-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang QQihang
2Wang HHan
3Liu SSiying
4Wang GGuangke

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,153,209The treatment of idiopathic sudden sensorineural hearing loss.Otolaryngol Clin North Am1975https://conductscience.org/library/papers/1153209PubMed
223,844,064Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.PLoS One2013https://conductscience.org/library/papers/23844064PubMed
323,168,496Relationship between mean platelet volume and mitral annular calcification.Blood Coagul Fibrinolysis2013https://conductscience.org/library/papers/23168496PubMed
424,427,597Mean platelet volume: is it a predictive parameter in the diagnosis of sudden sensorineural hearing loss?Indian J Otolaryngol Head Neck Surg2013https://conductscience.org/library/papers/24427597PubMed
527,732,958Prognostic significance of neutrophil-lymphocyteratio/platelet-lymphocyteratioin lung cancers: a meta-analysis.Oncotarget2016https://conductscience.org/library/papers/27732958PubMed
629,908,183MIF protects against oxygen-glucose deprivation-induced ototoxicity in HEI-OC1 cochlear cells by enhancement of Akt-Nrf2-HO-1 pathway.Biochem Biophys Res Commun2018https://conductscience.org/library/papers/29908183PubMed
733,679,706The Immune System Can Hear Noise.Front Immunol2020https://conductscience.org/library/papers/33679706PubMed
827,712,131Sudden sensorineural hearing loss: is there a relationship between routine haematological parameters and audiogram shapes?Int J Audiol2017https://conductscience.org/library/papers/27712131PubMed
924,756,737Mean platelet volume in nasal polyps.West Indian Med J2013https://conductscience.org/library/papers/24756737PubMed
1023,948,792Relationship between mean platelet volume and major depression.J Clin Psychopharmacol2013https://conductscience.org/library/papers/23948792PubMed

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42,694,224Serum ENA-78, CXCL1, and caspase-3 are associated with disease severity and early hearing recovery in idiopathic sudden sensorineural hearing loss.Front Neurosci2026https://conductscience.org/library/papers/42694224PubMed
42,645,126Diabetes Mellitus as a Risk Factor in Recurrent Vestibular Disorders: An Update.Audiol Res2026https://conductscience.org/library/papers/42645126PubMed
42,057,737Novel Systemic Inflammatory Indices (SII and SIRI) as Mediators Between BMI and Hearing Loss.Mediators Inflamm2026https://conductscience.org/library/papers/42057737PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CRP1,401PubTator's text mininghttps://conductscience.org/library/genes/1401

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41567673

GET https://conductscience.org/api/papers/v1/41567673/references?page=2